Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Polzer, S.
Right arrow Articles by Schreiber, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polzer, S.
Right arrow Articles by Schreiber, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, 2001, Vol. 11, No. 1 11-19
© 2001 Oxford University Press

Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1

Svenja Polzer, Matthias T. Dittmar2, Herbert Schmitz, Bernd Meyer3, Harm Müller, Hans-Georg Kräusslich2 and Michael Schreiber1

Bernhard Nocht Institute for Tropical Medicine, Bernhard Nocht Strasse 75, 20359 Hamburg, Germany, 2Heinrich Pette Institute, Martinistrasse 52, 20251 Hamburg, Germany, and 3Institute for Organic Chemistry University of Hamburg, Martin-Luther-King-Pl. 6, 20146 Hamburg, Germany

We describe mutants of human immunodeficiency virus type-1 (HIV-1) strain NL4-3, which are lacking the thirteenth, fifteenth, or seventeenth sites for N-linked glycosylation (g13, g15, g17) of the envelope protein gp120. All three sites are located within the hypervariable V3 loop region of gp120. Those mutants lacking carbohydrates g15 or combinations of g15/g17 showed markedly higher infectivity for GHOST cells (human osteosarcoma cells) expressing CXCR4 (GHOST-X4), compared to the fully glycosylated NL4-3 wild type virus. In addition, these mutants could also infect cells which exhibits low background expression of CXCR4, corresponding to <10% of that observed for GHOST-X4 cells. In addition to the enhanced infectivity observed, mutants lacking g15 and g17 showed increased resistance to inhibition by SDF-1, the natural ligand of CXCR4. Thus, loss of the oligosaccharides g15 and g17 in the V3 region of gp120 markedly influences CXCR4-specific infection.

1 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
R. J. Brown, G. C. Miller, N. Griffon, C. J. Long, and D. J. Rader
Glycosylation of endothelial lipase at asparagine-116 reduces activity and the hydrolysis of native lipoproteins in vitro and in vivo
J. Lipid Res., May 1, 2007; 48(5): 1132 - 1139.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
P. Clevestig, L. Pramanik, T. Leitner, and A. Ehrnst
CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-linked glycosylation site.
J. Gen. Virol., March 1, 2006; 87(Pt 3): 607 - 612.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. Luftenegger, M. Picard-Maureau, N. Stanke, A. Rethwilm, and D. Lindemann
Analysis and Function of Prototype Foamy Virus Envelope N Glycosylation
J. Virol., June 15, 2005; 79(12): 7664 - 7672.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Bardor, D. H. Nguyen, S. Diaz, and A. Varki
Mechanism of Uptake and Incorporation of the Non-human Sialic Acid N-Glycolylneuraminic Acid into Human Cells
J. Biol. Chem., February 11, 2005; 280(6): 4228 - 4237.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Gordon, T. De Oliveira, K. Bishop, H. M. Coovadia, L. Madurai, S. Engelbrecht, E. Janse van Rensburg, A. Mosam, A. Smith, and S. Cassol
Molecular Characteristics of Human Immunodeficiency Virus Type 1 Subtype C Viruses from KwaZulu-Natal, South Africa: Implications for Vaccine and Antiretroviral Control Strategies
J. Virol., February 15, 2003; 77(4): 2587 - 2599.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.